Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Umbrella Long-Term Follow-Up Protocol
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * The patient must reside in the U.S. on the date of enrollment to ALTE05N1 * All patients and/or their parents or legal guardians must sign a written informed consent * All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met
About the study
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
What is being tested
- Assessment of Therapy Complications (procedure)
- Questionnaire Administration (other)
Sponsor: Children's Oncology Group · Participants: 25,000 · Started: Jul 17, 2008
Contact the study team
Official record on ClinicalTrials.gov — NCT00736749
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.